These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

52 related articles for article (PubMed ID: 21619383)

  • 1. QT response after a test dose and during maintenance therapy with AZD1305 in patients with atrial fibrillation: a double-blind, randomized, placebo-controlled trial.
    Egstrup K; Bergfeldt L; Duris T; Gullestad L; Kochmanski M; Kuśnierz B; Nielsen T; Sawicki S; Aunes-Jansson M; Edvardsson N; Frison L; Johansson S; Berggren A
    Am J Cardiovasc Drugs; 2011 Jun; 11(3):199-208. PubMed ID: 21619383
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacological cardioversion of atrial fibrillation--a double-blind, randomized, placebo-controlled, multicentre, dose-escalation study of AZD1305 given intravenously.
    Rónaszéki A; Alings M; Egstrup K; Gaciong Z; Hranai M; Király C; Sereg M; Figatowski W; Bondarov P; Johansson S; Frison L; Edvardsson N; Berggren A
    Europace; 2011 Aug; 13(8):1148-56. PubMed ID: 21561900
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomized invasive cardiac electrophysiology study of the combined ion channel blocker AZD1305 in patients after catheter ablation of atrial flutter.
    Toivonen L; Raatikainen P; Walfridsson H; Englund A; Hegbom F; Anfinsen OG; Gjesdal K; Pehrson S; Johansson S; Frison L; Berggren AR; Edvardsson N
    J Cardiovasc Pharmacol; 2010 Sep; 56(3):300-8. PubMed ID: 20588189
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Electrophysiologic and antiarrhythmic effects of AZD1305 in canine pulmonary vein sleeves.
    Sicouri S; Carlsson L; Antzelevitch C
    J Pharmacol Exp Ther; 2010 Jul; 334(1):255-9. PubMed ID: 20360353
    [TBL] [Abstract][Full Text] [Related]  

  • 5. AZD1305 exerts atrial predominant electrophysiological actions and is effective in suppressing atrial fibrillation and preventing its reinduction in the dog.
    Burashnikov A; Zygmunt AC; Di Diego JM; Linhardt G; Carlsson L; Antzelevitch C
    J Cardiovasc Pharmacol; 2010 Jul; 56(1):80-90. PubMed ID: 20386458
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of stroke in ATHENA: a placebo-controlled, double-blind, parallel-arm trial to assess the efficacy of dronedarone 400 mg BID for the prevention of cardiovascular hospitalization or death from any cause in patients with atrial fibrillation/atrial flutter.
    Connolly SJ; Crijns HJ; Torp-Pedersen C; van Eickels M; Gaudin C; Page RL; Hohnloser SH;
    Circulation; 2009 Sep; 120(13):1174-80. PubMed ID: 19752319
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dronedarone for maintenance of sinus rhythm in atrial fibrillation or flutter.
    Singh BN; Connolly SJ; Crijns HJ; Roy D; Kowey PR; Capucci A; Radzik D; Aliot EM; Hohnloser SH;
    N Engl J Med; 2007 Sep; 357(10):987-99. PubMed ID: 17804843
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomized, controlled trial of RSD1235, a novel anti-arrhythmic agent, in the treatment of recent onset atrial fibrillation.
    Roy D; Rowe BH; Stiell IG; Coutu B; Ip JH; Phaneuf D; Lee J; Vidaillet H; Dickinson G; Grant S; Ezrin AM; Beatch GN;
    J Am Coll Cardiol; 2004 Dec; 44(12):2355-61. PubMed ID: 15607398
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug-induced QT-interval prolongation and proarrhythmic risk in the treatment of atrial arrhythmias.
    Shantsila E; Watson T; Lip GY
    Europace; 2007 Sep; 9 Suppl 4():iv37-44. PubMed ID: 17766322
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A randomized trial of circumferential pulmonary vein ablation versus antiarrhythmic drug therapy in paroxysmal atrial fibrillation: the APAF Study.
    Pappone C; Augello G; Sala S; Gugliotta F; Vicedomini G; Gulletta S; Paglino G; Mazzone P; Sora N; Greiss I; Santagostino A; LiVolsi L; Pappone N; Radinovic A; Manguso F; Santinelli V
    J Am Coll Cardiol; 2006 Dec; 48(11):2340-7. PubMed ID: 17161267
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rapid conversion of persistent atrial fibrillation to sinus rhythm by intravenous AZD7009.
    Geller JC; Egstrup K; Kulakowski P; Rosenqvist M; Jansson MA; Berggren A; Edvardsson N; Sager P; Crijns HJ
    J Clin Pharmacol; 2009 Mar; 49(3):312-22. PubMed ID: 19129422
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prediction of drug-related morphological changes of the T wave.
    Tjäderborn M; Aunes-Jansson M; Samuelsson E; Frison L; Johansson S; Berggren A; Edvardsson N
    Scand Cardiovasc J; 2010 Aug; 44(4):215-22. PubMed ID: 20429697
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A randomized controlled trial of magnesium sulfate, in addition to usual care, for rate control in atrial fibrillation.
    Davey MJ; Teubner D
    Ann Emerg Med; 2005 Apr; 45(4):347-53. PubMed ID: 15795711
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship among amiodarone, new class III antiarrhythmics, miscellaneous agents and acquired long QT syndrome.
    Riera AR; Uchida AH; Ferreira C; Ferreira Filho C; Schapachnik E; Dubner S; Zhang L; Moffa PJ
    Cardiol J; 2008; 15(3):209-19. PubMed ID: 18651412
    [TBL] [Abstract][Full Text] [Related]  

  • 15. QT interval prolongation and torsades de pointes due to a coadministration of metronidazole and amiodarone.
    Kounas SP; Letsas KP; Sideris A; Efraimidis M; Kardaras F
    Pacing Clin Electrophysiol; 2005 May; 28(5):472-3. PubMed ID: 15869686
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rhythm- and rate-controlling effects of dronedarone in patients with atrial fibrillation (from the ATHENA trial).
    Page RL; Connolly SJ; Crijns HJ; van Eickels M; Gaudin C; Torp-Pedersen C; Hohnloser SH;
    Am J Cardiol; 2011 Apr; 107(7):1019-22. PubMed ID: 21296333
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of oral magnesium, alone or as an adjuvant to sotalol, after cardioversion in patients with persistent atrial fibrillation.
    Frick M; Darpö B; Ostergren J; Rosenqvist M
    Eur Heart J; 2000 Jul; 21(14):1177-85. PubMed ID: 10924301
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A randomized, placebo-controlled trial of propafenone in the prophylaxis of paroxysmal supraventricular tachycardia and paroxysmal atrial fibrillation. UK Propafenone PSVT Study Group.
    Circulation; 1995 Nov; 92(9):2550-7. PubMed ID: 7586356
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Practical regimen for amiodarone use in preventing postoperative atrial fibrillation.
    Zebis LR; Christensen TD; Thomsen HF; Mikkelsen MM; Folkersen L; Sørensen HT; Hjortdal VE
    Ann Thorac Surg; 2007 Apr; 83(4):1326-31. PubMed ID: 17383335
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amiodarone versus sotalol for atrial fibrillation.
    Singh BN; Singh SN; Reda DJ; Tang XC; Lopez B; Harris CL; Fletcher RD; Sharma SC; Atwood JE; Jacobson AK; Lewis HD; Raisch DW; Ezekowitz MD;
    N Engl J Med; 2005 May; 352(18):1861-72. PubMed ID: 15872201
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.